Rhode Island Cannabis Market Overview

Last verified: March 2026

Rhode Island's cannabis market is a study in artificial scarcity. With only 8 stores serving 1.1 million residents, each location generates approximately $17 million per year — the highest per-store figure in any legal cannabis state. But the same license cap that drives those numbers also constrains total market growth and pushes consumers to neighboring Massachusetts, where prices are lower and options are far more abundant.

Key Market Metrics

Growth Deceleration

Rhode Island's cannabis market grew 26.7% in 2024 — strong by any measure. But 2025 brought a dramatic slowdown: growth fell to just 1.8%. The market has essentially plateaued with only 8 retail stores. Without new locations to capture demand currently lost to Massachusetts and Connecticut, or to serve underserved regions of the state, the growth ceiling is real.

Revenue Projections vs. Reality

The 280E Burden

While per-store revenue is the highest in America, margins tell a different story. Federal Section 280E prevents cannabis businesses from deducting normal operating expenses — rent, payroll, utilities, insurance — because marijuana remains Schedule I. For some Rhode Island operators, the combined state (20%) and federal tax burden produces effective tax rates of 60–80%.

This means a dispensary generating $17 million in revenue may retain only a fraction of what a similarly-sized business in any other industry would keep. The 280E problem is national, but it hits hardest in high-revenue, high-fee states like Rhode Island.

Recreational vs. Medical Split

Recreational sales account for approximately 82% of total revenue ($97.9M of $120M in 2025), with medical at 18% ($22M). The medical share has declined steadily as recreational access expanded, a pattern seen in every state that transitions from medical-only to dual markets. However, Rhode Island's medical program remains active due to lower tax rates (11% vs. 20%) and higher purchase limits.